{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:54:13Z","timestamp":1771462453207,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ad.2022.01.028","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:08:27Z","timestamp":1645128507000},"page":"543-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Formulaci\u00f3n magistral en pacientes con genodermatosis. Impacto en la calidad de vida: un estudio transversal"],"prefix":"10.1016","volume":"113","author":[{"given":"M.","family":"Oro-Ayude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Batalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"D\u00e1vila-Pousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gonz\u00e1lez-Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2022.01.028_bib0150","year":"2009","journal-title":"\u00bfQu\u00e9 es una enfermedad rara?"},{"key":"10.1016\/j.ad.2022.01.028_bib0155","year":"2019","journal-title":"FAQs About Rare Diseases"},{"key":"10.1016\/j.ad.2022.01.028_bib0160","unstructured":"Consejo de Europa. Resoluci\u00f3n CM\/ResAP (2011) 1. Exigencias relativas a la garant\u00eda de calidad y de inocuidad de los medicamentos preparados en las farmacias para las necesidades especiales de los pacientes [consultado 7 Jul 2021]. Disponible en: https:\/\/farmaquimicasur.com\/wp-content\/uploads\/2018\/06\/Resoluci%C3%B3n-Formulacion-CM-ResAP-20111-esp.pdf, 2018."},{"key":"10.1016\/j.ad.2022.01.028_bib0165","first-page":"9746","article-title":"Real Decreto 175\/2001 sobre Normas de correcta elaboraci\u00f3n y control de calidad en formulaciones magistrales y preparados oficinales","volume":"65","year":"2001","journal-title":"BOE"},{"key":"10.1016\/j.ad.2022.01.028_bib0170","year":"2019","journal-title":"Plataforma Online de F\u00f3rmulas Magistrales para Enfermedades Raras"},{"key":"10.1016\/j.ad.2022.01.028_bib0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/pde.13489","article-title":"Topical N-acetylcysteine in ichthyosis: experience in 18 patients","volume":"35","author":"Kaplan","year":"2018","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1525-1470.2011.01375.x","article-title":"Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis","volume":"28","author":"Bassotti","year":"2011","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0185","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/pde.12305","article-title":"Topical N-Acetylcysteine for the Treatment of Lamellar Ichthyosis: An Improved Formula","volume":"31","author":"D\u00e1vila-Seijo","year":"2014","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ad.2020.11.006","article-title":"The Most Useful Pharmaceutical Formulations (Individualized Medications) in Pediatric Dermatology: A Review","volume":"112","author":"Abarca Lach\u00e9n","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"key":"10.1016\/j.ad.2022.01.028_bib0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/pde.13638","article-title":"Topical carbocysteine: a new option for the treatment of ichthyosis","volume":"35","author":"Batalla","year":"2018","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0200","year":"2018","journal-title":"Study of Alwextin\u00ae Cream in Treating Epidermolysis Bullosa"},{"key":"10.1016\/j.ad.2022.01.028_bib0205","year":"2018","journal-title":"ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa"},{"key":"10.1016\/j.ad.2022.01.028_bib0210","year":"2013","journal-title":"Search Orphan Drug Designations and Approvals"},{"key":"10.1016\/j.ad.2022.01.028_bib0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jdv.12665","article-title":"Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex","volume":"29","author":"Balestri","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.028_bib0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaad.2018.10.070","article-title":"Topical use of mammalian target of rapamycin inhibitors in dermatology: a systematic review with meta-analysis","volume":"80","author":"Leducq","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0225","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2018.1408","article-title":"Sirolimus gel treatment vs placebo for facial angiofibromas in patients with tuberous sclerosis complex: a randomized clinical trial","volume":"154","author":"Wataya-Kaneda","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0230","year":"2017","journal-title":"Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex"},{"key":"10.1016\/j.ad.2022.01.028_bib0235","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ad.2012.11.020","article-title":"Current options for the treatment of facial angiofibromas","volume":"105","author":"Salido-Vallejo","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2022.01.028_bib0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2013.01.022","article-title":"IQoL-32: A new ichthyosis-specific measure of quality of life","volume":"69","author":"Dreyfus","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0245","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","article-title":"Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument","volume":"161","author":"Frew","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0250","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.0022-202X.2005.23911.x","article-title":"Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families","volume":"125","author":"Chamlin","year":"2005","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0255","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/pde.12933","article-title":"Effect of angiofibromas on quality of life and access to care in tuberous sclerosis patients and their caregivers","volume":"33","author":"Crall","year":"2016","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2340\/00015555-1710","article-title":"Factors associated with impaired quality of life in adult patients suffering from ichthyosis","volume":"94","author":"Dreyfus","year":"2014","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2022.01.028_bib0265","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10701.x","article-title":"Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups","volume":"166","author":"Mazereeuw-Hautier","year":"2012","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5021\/ad.2016.28.1.6","article-title":"Quality of life and economic burden in recessive dystrophic epidermolysis bullosa","volume":"28","author":"Jeon","year":"2016","journal-title":"Ann Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/pde.12262","article-title":"Hand function and quality of life in children with epidermolysis bullosa","volume":"31","author":"Eismann","year":"2014","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2022.01.028_bib0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13023-017-0666-5","article-title":"Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex","volume":"12","author":"Brun","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ad.2022.01.028_bib0285","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jdv.15337","article-title":"Epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire","volume":"33","author":"Chernyshov","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2022.01.028_bib0290","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/bjd.14072","article-title":"Development and validation of an epidermolysis bullosa family\/parental burden score","volume":"173","author":"Dufresne","year":"2015","journal-title":"Br J Dermatol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:13:50Z","timestamp":1757553230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731022001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0001731022001569"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2022.01.028","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulaci\u00f3n magistral en pacientes con genodermatosis. Impacto en la calidad de vida: un estudio transversal","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2022.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}